• Zai Lab Announces Participation in November Investor Conferences

    Source: Nasdaq GlobeNewswire / 31 Oct 2022 07:52:02   America/New_York

    SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will participate in the following investor conferences in November:

    Goldman Sachs Asia Pacific Healthcare Forum 2022
    Panel discussion: Tuesday, November 15, 2022 at 9:30 a.m. HKT

    Morgan Stanley 21st Annual Asia Pacific Summit
    Meetings: Wednesday, November 16, 2022
    Location: Singapore

    Jefferies London Healthcare Conference
    Fireside Chat: Thursday, November 17, 2022 at 1:30 p.m. GMT

    2022 BioCentury-BayHelix East-West Summit
    Panel discussions: Several sessions available beginning on November 5, 2022 through December 30, 2022

    Webcast link of Jefferies London Healthcare Conference will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be available for 90 days following the event.

    About Zai Lab

    Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the world. Our goal is to leverage our competencies and resources to positively impact human health worldwide.

    For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

    For more information, please contact:

    Investor Relations: Lina Zhang
    +86 136 8257 6943
    lina.zhang@zailaboratory.com

    Media: Christine Drury / Xiaoyu Chen
    +1 (317) 385-9227 / +86 185 0015 5011
    christine.drury@zailaboratory.com / xiaoyu.chen@zailaboratory.com 

    Zai Lab Limited

    Source: Zai Lab Limited


    Primary Logo

Share on,